TCL Archive In Brief: NCI To Move Todaro’s Lab to FCR; Cinnamyl Anthranilate Was Carciogenic In Bioassay March 28, 1980
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive Triple Combination Chemotherapy Effective For Advanced Colorectal Cancer, Trial Finds January 27, 2006
